Skip to main content
Clinical Trials/CTRI/2021/04/032521
CTRI/2021/04/032521
Completed
N/A

Role of Metabolic Evaluation in Infants presenting with Global Developmental Delay

Dr Rochelle Natasha Gomes0 sites53 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: E889- Metabolic disorder, unspecifiedHealth Condition 2: F88- Other disorders of psychological development
Sponsor
Dr Rochelle Natasha Gomes
Enrollment
53
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 30, 2022
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Dr Rochelle Natasha Gomes

Eligibility Criteria

Inclusion Criteria

  • 1\. Children aged 1 month to 1 year admitted in the Department of Paediatrics and presenting with GDD (global developmental delay with unclear etiology, progressive encephalopathy with seizures, hypotonia with or without poor feeding, failure to thrive, respiratory distress or vomiting).
  • 2\. Children with hypoglycaemic encephalopathy.

Exclusion Criteria

  • 1\. Children lesser than 1 month of age or older than 1 year at presentation.
  • 2\. Children with identified causes of GDD such as perinatal asphyxia/ hypoxic ischaemic encephalopathy stage 2 or 3, TORCH infections, post\-meningitis sequelae, chromosomal disorder, hypothyroidism etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials